Hormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models. [electronic resource]
Producer: 20120216Description: 4550-61 p. digitalISSN:- 1945-7170
- Anilides -- pharmacology
- Cell Line
- DNA (Cytosine-5-)-Methyltransferases -- genetics
- DNA Methyltransferase 3A
- Drug Resistance
- Epigenomics
- Gene Expression Regulation, Neoplastic -- drug effects
- Hormones -- pharmacology
- Humans
- Male
- Nitriles -- pharmacology
- Prostatic Neoplasms -- drug therapy
- Tosyl Compounds -- pharmacology
- DNA Methyltransferase 3B
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.